Table 3.

Number of patients discontinuing treatment with glatiramer acetate and their motives for this interruption

Reason for discontinuation of treatment	Number of patients	Percentage of the number of patients who interrupted (n = 113)	Percentage of total number of patients (n = 1131)
Medical conduct	53	47%	5%
Patient’s own choice	20	18%	2%
Non-serious adverse event	18	16%	2%
Immediate reaction post-injection	9	8%	<1%
Reaction in the site of injection	8	7%	<1%
Pregnancy	4	4%	<1%
Hematopoietic stem cell transplantation	1	1%	<1%